Large-scale testing (Phase 3)UnknownNCT00728078
What this trial is testing
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200